Aim: The aim of the present study was to investigate the reliability of macular microvasculature measurements in normal subjects by Heidelberg Spectralis II optical coherence tomography angiography (OCT-A) in combination with a newly made software. Subjects and Methods: This prospective study included 23 eyes of 23 persons from the Erlangen Glaucoma Registry (ISSN 2191–5008, CS-2011; NTC00494923). The subjects underwent a complete clinical, standardized ophthalmologic examination to rule out any eye disease. En face OCT-A imaging was done using Heidelberg Spectralis II OCT (Heidelberg, Germany). Images were recorded with a 15 × 15° angle and a lateral resolution of 5.7 µm/pixel, resulting in a retinal section of 2.9 × 2.9 mm. The Erlangen-Angio-Tool (EA-Tool) OCT-A application performed multiple segmentations, allowing analysis of the vessel density in 12 segments. The software was coded in MATLAB. Macular data on the superficial vascular plexus (SVP), intermediate capillary plexus (ICP), and deep capillary plexus (DCP) were exported into the application and analyzed separately. The EA-Tool calculated the percentage of “white area” in the “total area” of the region of interest, called vessel density. Foveolar avascular zones (FAZs) of the SVP, ICP, and DCP were calculated manually. To investigate the reproducibility of the new software, individual scans (SVP, ICP, and DCP) were analyzed twice with the EA-Tool and intraclass coefficients (ICCs) of the vessel density values were calculated. Statistical analysis was performed with SPSS version 21.0. Results: The mean vessel density of the SVP ranged between 30.4 and 33.5, that of the ICP between 20.9 and 24.7, and that of the DCP between 23.5 and 27.6. Bland-Altman plots showed a good reliability of two consecutive scans of each sector (S1–S12) in the SVP, ICP, and DCP. Testing reproducibility, no statistically significantly different sectorial coefficients of variation of the SVP, ICP, and DCP were observed (p > 0.05). The mean FAZ area of the SVP was 0.43 ± 0.16 mm2, that of the ICP 0.28 ± 0.1 mm2, and that of the DCP 0.44 ± 0.12 mm2. Conclusions: Spectralis OCT II, in combination with the semiautomated vessel density software EA-Tool, showed good or even excellent ICCs in 75% of all segments of the SVP, ICP, and DCP. The ICCs for the FAZ area in the SVP, ICP, and DCP were excellent.

1.
Makita
S
,
Hong
Y
,
Yamanari
M
,
Yatagai
T
,
Yasuno
Y
.
Optical coherence angiography
.
Opt Express
.
2006
Aug
;
14
(
17
):
7821
40
.
[PubMed]
1094-4087
2.
Jia
Y
,
Tan
O
,
Tokayer
J
,
Potsaid
B
,
Wang
Y
,
Liu
JJ
, et al
Split-spectrum amplitude-decorrelation angiography with optical coherence tomography
.
Opt Express
.
2012
Feb
;
20
(
4
):
4710
25
.
[PubMed]
1094-4087
3.
Shin
JW
,
Sung
KR
,
Lee
JY
,
Kwon
J
,
Seong
M
.
Optical coherence tomography angiography vessel density mapping at various retinal layers in healthy and normal tension glaucoma eyes
.
Graefes Arch Clin Exp Ophthalmol
.
2017
Jun
;
255
(
6
):
1193
202
.
[PubMed]
0721-832X
4.
Park JJ, Soetikno BT, Fawzi AA. Characterization of the middle capillary plexus using optical coherence tomography angiography in healthy and diabetic eyes. Retina. 2016 Nov;36(11):2039–50.
5.
Campbell J, Zhang M, Hwang T, Bailey S, Wilson D, Jia Y, et al. Detailed vascular anatomy of the human retina by projection-resolved optical coherence tomography angiography. Sci Rep. 2017 Feb;7:42201.
6.
Munk MR, Giannakaki-Zimmermann H, Berger L, Huf W, Ebneter A, Wolf S, et a. OCT-angiography: a qualitative and quantitative comparison of 4 OCT-A devices. PLoS One. 2017 May;12(5):e0177059.
7.
Park
JJ
,
Soetikno
BT
,
Fawzi
AA
.
Characterization of the middle capillary plexus using optical coherence tomography angiography in healthy and diabetic eyes. Retina (Philadelphia, Pa) 36: 2039 Campbell J, Zhang M, Hwang T, Bailey S, Wilson D, Jia Y, Huang D (2017) Detailed vascular anatomy of the human retina by projection-resolved optical coherence tomography angiography. Sci Rep-Uk 7: 42201 Munk MR, Giannakaki-Zimmermann H, Berger L, Huf W, Ebneter A, Wolf S, Zinkernagel MS (2017) OCT-angiography: A qualitative and quantitative comparison of 4 OCT-A devices. PloS one 12: e0177059 Arya M, Rebhun CB, Alibhai AY, Chen X, Moreira-Neto C, Baumal CR, Reichel E, Witkin AJ, Duker JS, Sadda SR (2018) Parafoveal Retinal Vessel Density Assessment by Optical Coherence Tomography Angiography in Healthy Eyes
.
Ophthalmic Surg Lasers Imaging Retina
.
2016
;
49
:
S5
17
.2325-8160
8.
Lupidi
M
,
Coscas
F
,
Cagini
C
,
Fiore
T
,
Spaccini
E
,
Fruttini
D
, et al
Automated quantitative analysis of retinal microvasculature in normal eyes on optical coherence tomography angiography
.
Am J Ophthalmol
.
2016
Sep
;
169
:
9
23
.
[PubMed]
0002-9394
9.
Rabiolo
A
,
Gelormini
F
,
Sacconi
R
,
Cicinelli
MV
,
Triolo
G
,
Bettin
P
, et al
Comparison of methods to quantify macular and peripapillary vessel density in optical coherence tomography angiography
.
PLoS One
.
2018
Oct
;
13
(
10
):
e0205773
.
[PubMed]
1932-6203
10.
Frangi
AF
,
Niessen
WJ
,
Vincken
KL
,
Viergever
MA
. (
1998
)
Multiscale vessel enhancement filtering.
Springer Berlin Heidelberg, Berlin, Heidelberg, pp. 130-137.
11.
Otsu
N
.
A threshold selection method from gray-level histograms
.
IEEE Trans Syst Man Cybern
.
1979
;
9
(
1
):
62
6
. 0018-9472
12.
Giavarina
D
.
Understanding Bland Altman analysis
.
Biochem Med (Zagreb)
.
2015
Jun
;
25
(
2
):
141
51
.
[PubMed]
1330-0962
13.
de Carlo
TE
,
Chin
AT
,
Bonini Filho
MA
,
Adhi
M
,
Branchini
L
,
Salz
DA
, et al
Detection of microvascular changes in eyes of patients with diabetes but not clinical diabetic retinopathy using optical coherence tomography angiography
.
Retina
.
2015
Nov
;
35
(
11
):
2364
70
.
[PubMed]
0275-004X
14.
Chalam
KV
,
Sambhav
K
.
Optical coherence tomography angiography in retinal diseases
.
J Ophthalmic Vis Res
.
2016
Jan-Mar
;
11
(
1
):
84
92
.
[PubMed]
2008-2010
15.
Wylęgała
A
.
Principles of OCTA and Applications in Clinical Neurology
.
Curr Neurol Neurosci Rep
.
2018
Oct
;
18
(
12
):
96
.
[PubMed]
1528-4042
16.
Takase
N
,
Nozaki
M
,
Kato
A
,
Ozeki
H
,
Yoshida
M
,
Ogura
Y
.
Enlargement of foveal avascular zone in diabetic eyes evaluated by en face optical coherence tomography angiography
.
Retina
.
2015
Nov
;
35
(
11
):
2377
83
.
[PubMed]
0275-004X
17.
Choi
J
,
Kwon
J
,
Shin
JW
,
Lee
J
,
Lee
S
,
Kook
MS
.
Quantitative optical coherence tomography angiography of macular vascular structure and foveal avascular zone in glaucoma
.
PLoS One
.
2017
Sep
;
12
(
9
):
e0184948
.
[PubMed]
1932-6203
18.
Dimitrova
G
,
Chihara
E
,
Takahashi
H
,
Amano
H
,
Okazaki
K
.
Quantitative retinal optical coherence tomography angiography in patients with diabetes without diabetic retinopathy
.
Invest Ophthalmol Vis Sci
.
2017
Jan
;
58
(
1
):
190
6
.
[PubMed]
0146-0404
19.
Jia
Y
,
Bailey
ST
,
Wilson
DJ
,
Tan
O
,
Klein
ML
,
Flaxel
CJ
, et al
Quantitative optical coherence tomography angiography of choroidal neovascularization in age-related macular degeneration
.
Ophthalmology
.
2014
Jul
;
121
(
7
):
1435
44
.
[PubMed]
0161-6420
20.
Jia
Y
,
Wei
E
,
Wang
X
,
Zhang
X
,
Morrison
JC
,
Parikh
M
, et al
Optical coherence tomography angiography of optic disc perfusion in glaucoma
.
Ophthalmology
.
2014
Jul
;
121
(
7
):
1322
32
.
[PubMed]
0161-6420
21.
Hwang
TS
,
Zhang
M
,
Bhavsar
K
,
Zhang
X
,
Campbell
JP
,
Lin
P
, et al
Visualization of 3 distinct retinal plexuses by projection-resolved optical coherence tomography angiography in diabetic retinopathy
.
JAMA Ophthalmol
.
2016
Dec
;
134
(
12
):
1411
9
.
[PubMed]
2168-6165
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.